nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—BCAT1—gonad—hematologic cancer	0.00736	0.0878	CbGeAlD
Gabapentin—CACNA1B—lung—hematologic cancer	0.00715	0.0853	CbGeAlD
Gabapentin—CACNA1B—testis—hematologic cancer	0.00674	0.0805	CbGeAlD
Gabapentin—ADORA1—hematopoietic system—hematologic cancer	0.00616	0.0735	CbGeAlD
Gabapentin—BCAT1—lung—hematologic cancer	0.00562	0.0671	CbGeAlD
Gabapentin—BCAT1—testis—hematologic cancer	0.0053	0.0633	CbGeAlD
Gabapentin—CACNA2D2—lung—hematologic cancer	0.00515	0.0615	CbGeAlD
Gabapentin—CACNA1B—lymph node—hematologic cancer	0.00489	0.0583	CbGeAlD
Gabapentin—CACNA2D2—testis—hematologic cancer	0.00486	0.058	CbGeAlD
Gabapentin—CACNA2D1—bone marrow—hematologic cancer	0.00409	0.0488	CbGeAlD
Gabapentin—BCAT1—lymph node—hematologic cancer	0.00384	0.0459	CbGeAlD
Gabapentin—CACNA2D1—lung—hematologic cancer	0.00371	0.0442	CbGeAlD
Gabapentin—ADORA1—lung—hematologic cancer	0.00358	0.0427	CbGeAlD
Gabapentin—CACNA2D2—lymph node—hematologic cancer	0.00352	0.0421	CbGeAlD
Gabapentin—CACNA2D1—testis—hematologic cancer	0.0035	0.0417	CbGeAlD
Gabapentin—ADORA1—testis—hematologic cancer	0.00337	0.0403	CbGeAlD
Gabapentin—CACNA2D1—lymph node—hematologic cancer	0.00254	0.0302	CbGeAlD
Gabapentin—ADORA1—lymph node—hematologic cancer	0.00245	0.0292	CbGeAlD
Gabapentin—BCAT1—Metabolism—NQO1—hematologic cancer	0.000133	0.000997	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOR2—hematologic cancer	0.000132	0.000995	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL3RA—hematologic cancer	0.000131	0.000987	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HDAC11—hematologic cancer	0.000129	0.000968	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RGS2—hematologic cancer	0.000127	0.000952	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—IDH1—hematologic cancer	0.000126	0.000948	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYCS—hematologic cancer	0.000126	0.000943	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—TRH—hematologic cancer	0.000125	0.000941	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—TRIO—hematologic cancer	0.000125	0.000941	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TXN—hematologic cancer	0.000125	0.000937	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTO1—hematologic cancer	0.000125	0.000937	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCC3—hematologic cancer	0.000125	0.000937	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HSP90AA1—hematologic cancer	0.000125	0.000937	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BCR—hematologic cancer	0.000124	0.000928	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PDE4B—hematologic cancer	0.000123	0.000924	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CNR2—hematologic cancer	0.000123	0.000924	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SPHK1—hematologic cancer	0.000122	0.000917	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—LPAR1—hematologic cancer	0.000121	0.000912	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RAC2—hematologic cancer	0.000121	0.000909	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—HRAS—hematologic cancer	0.000118	0.00089	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—UGT1A1—hematologic cancer	0.000117	0.000881	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADCY7—hematologic cancer	0.000116	0.000869	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HDAC10—hematologic cancer	0.000115	0.000863	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—JUN—hematologic cancer	0.000115	0.000862	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC22A1—hematologic cancer	0.000114	0.000857	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CRABP1—hematologic cancer	0.000114	0.000857	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PDE4B—hematologic cancer	0.000112	0.000839	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CNR2—hematologic cancer	0.000112	0.000839	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALOX5—hematologic cancer	0.000111	0.000835	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PTEN—hematologic cancer	0.000111	0.000834	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTP1—hematologic cancer	0.000111	0.000831	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RAC2—hematologic cancer	0.00011	0.000825	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	0.000109	0.000823	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—MAPK8—hematologic cancer	0.000109	0.000815	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NUP98—hematologic cancer	0.000108	0.000809	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—EP300—hematologic cancer	0.000106	0.000795	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ARHGEF12—hematologic cancer	0.000105	0.000789	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADCY7—hematologic cancer	0.000105	0.000789	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCB1—hematologic cancer	0.000105	0.000787	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTHLH—hematologic cancer	0.000105	0.000786	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ADCY7—hematologic cancer	0.000105	0.000785	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA3—hematologic cancer	0.000105	0.000785	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NUP214—hematologic cancer	0.000104	0.00078	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—hematologic cancer	0.000102	0.00077	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ARHGEF1—hematologic cancer	0.000102	0.000769	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTGER4—hematologic cancer	0.000102	0.000765	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTR—hematologic cancer	0.000102	0.000764	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NCOR1—hematologic cancer	0.000102	0.000764	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTM1—hematologic cancer	0.000102	0.000764	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCG2—hematologic cancer	0.000102	0.000764	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ENO2—hematologic cancer	9.97e-05	0.000749	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTT1—hematologic cancer	9.67e-05	0.000727	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL3—hematologic cancer	9.6e-05	0.000721	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTHLH—hematologic cancer	9.49e-05	0.000713	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SDC1—hematologic cancer	9.45e-05	0.00071	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTGER4—hematologic cancer	9.24e-05	0.000694	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL17—hematologic cancer	9.18e-05	0.00069	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGRN—hematologic cancer	9.18e-05	0.00069	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCR5—hematologic cancer	9.01e-05	0.000677	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCR4—hematologic cancer	8.99e-05	0.000675	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—hematologic cancer	8.99e-05	0.000675	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEF1—hematologic cancer	8.85e-05	0.000665	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNA13—hematologic cancer	8.7e-05	0.000654	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL3—hematologic cancer	8.67e-05	0.000651	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TIAM1—hematologic cancer	8.56e-05	0.000643	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RASGRP1—hematologic cancer	8.38e-05	0.00063	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL2—hematologic cancer	8.34e-05	0.000626	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JAK3—hematologic cancer	8.3e-05	0.000624	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCR4—hematologic cancer	8.16e-05	0.000613	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CD44—hematologic cancer	8.04e-05	0.000604	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NQO1—hematologic cancer	8.04e-05	0.000604	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL13—hematologic cancer	7.96e-05	0.000598	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR7—hematologic cancer	7.96e-05	0.000598	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL3—hematologic cancer	7.87e-05	0.000591	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NCOR2—hematologic cancer	7.86e-05	0.00059	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—HRAS—hematologic cancer	7.85e-05	0.00059	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CRKL—hematologic cancer	7.76e-05	0.000583	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL3RA—hematologic cancer	7.76e-05	0.000583	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RASGRP1—hematologic cancer	7.61e-05	0.000572	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYCS—hematologic cancer	7.6e-05	0.000571	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—hematologic cancer	7.57e-05	0.000569	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSP90AA1—hematologic cancer	7.56e-05	0.000568	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—hematologic cancer	7.55e-05	0.000567	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GRB2—hematologic cancer	7.54e-05	0.000567	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RGS2—hematologic cancer	7.48e-05	0.000562	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TRIO—hematologic cancer	7.4e-05	0.000556	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TRH—hematologic cancer	7.4e-05	0.000556	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CMA1—hematologic cancer	7.4e-05	0.000556	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGO2—hematologic cancer	7.24e-05	0.000544	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SPHK1—hematologic cancer	7.24e-05	0.000544	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LPAR1—hematologic cancer	7.17e-05	0.000539	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HDAC9—hematologic cancer	7.17e-05	0.000539	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—H3F3B—hematologic cancer	7.1e-05	0.000533	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CREBBP—hematologic cancer	7e-05	0.000526	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—hematologic cancer	6.93e-05	0.000521	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GRB2—hematologic cancer	6.85e-05	0.000514	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CSF2—hematologic cancer	6.74e-05	0.000506	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTP1—hematologic cancer	6.7e-05	0.000504	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CD—hematologic cancer	6.64e-05	0.000499	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CNR2—hematologic cancer	6.6e-05	0.000496	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDE4B—hematologic cancer	6.6e-05	0.000496	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—hematologic cancer	6.55e-05	0.000492	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF19—hematologic cancer	6.54e-05	0.000492	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCG—hematologic cancer	6.5e-05	0.000489	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—JAK1—hematologic cancer	6.5e-05	0.000489	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAC2—hematologic cancer	6.49e-05	0.000488	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DKK1—hematologic cancer	6.44e-05	0.000484	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT5B—hematologic cancer	6.39e-05	0.00048	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCB1—hematologic cancer	6.35e-05	0.000477	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3R1—hematologic cancer	6.27e-05	0.000471	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADCY7—hematologic cancer	6.2e-05	0.000466	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOR1—hematologic cancer	6.16e-05	0.000463	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTM1—hematologic cancer	6.16e-05	0.000463	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CSF2—hematologic cancer	6.12e-05	0.00046	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2RA—hematologic cancer	6.07e-05	0.000456	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—XIAP—hematologic cancer	6.03e-05	0.000453	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—JAK1—hematologic cancer	5.91e-05	0.000444	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCG—hematologic cancer	5.91e-05	0.000444	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SH2B3—hematologic cancer	5.88e-05	0.000442	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SMARCA4—hematologic cancer	5.88e-05	0.000442	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GZMB—hematologic cancer	5.84e-05	0.000439	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—hematologic cancer	5.78e-05	0.000435	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTNNA1—hematologic cancer	5.7e-05	0.000429	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EIF4EBP1—hematologic cancer	5.67e-05	0.000426	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL3—hematologic cancer	5.67e-05	0.000426	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HSPB1—hematologic cancer	5.67e-05	0.000426	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SDC1—hematologic cancer	5.61e-05	0.000421	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTHLH—hematologic cancer	5.61e-05	0.000421	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2RA—hematologic cancer	5.51e-05	0.000414	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTGER4—hematologic cancer	5.46e-05	0.00041	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—hematologic cancer	5.44e-05	0.000409	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LCK—hematologic cancer	5.43e-05	0.000408	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—H3F3A—hematologic cancer	5.32e-05	0.0004	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCZ—hematologic cancer	5.18e-05	0.000389	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—hematologic cancer	5.06e-05	0.00038	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PARP1—hematologic cancer	5e-05	0.000376	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTEN—hematologic cancer	5e-05	0.000376	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FBXW7—hematologic cancer	4.92e-05	0.00037	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HDAC2—hematologic cancer	4.82e-05	0.000362	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCR4—hematologic cancer	4.82e-05	0.000362	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—EP300—hematologic cancer	4.77e-05	0.000358	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CBL—hematologic cancer	4.7e-05	0.000353	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL3—hematologic cancer	4.65e-05	0.000349	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—hematologic cancer	4.59e-05	0.000345	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—hematologic cancer	4.57e-05	0.000344	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTPN1—hematologic cancer	4.57e-05	0.000344	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTPN11—hematologic cancer	4.51e-05	0.000339	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RASGRP1—hematologic cancer	4.5e-05	0.000338	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HSP90AA1—hematologic cancer	4.48e-05	0.000337	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SYK—hematologic cancer	4.48e-05	0.000337	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—hematologic cancer	4.45e-05	0.000334	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CREB1—hematologic cancer	4.37e-05	0.000329	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT1—hematologic cancer	4.32e-05	0.000325	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL2—hematologic cancer	4.28e-05	0.000321	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6R—hematologic cancer	4.27e-05	0.000321	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CREBBP—hematologic cancer	4.24e-05	0.000319	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3R1—hematologic cancer	4.2e-05	0.000316	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—JAK2—hematologic cancer	4.08e-05	0.000307	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAP2K1—hematologic cancer	4.07e-05	0.000305	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GRB2—hematologic cancer	4.04e-05	0.000304	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—hematologic cancer	4.04e-05	0.000303	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFA—hematologic cancer	4.04e-05	0.000303	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—hematologic cancer	4.02e-05	0.000302	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KITLG—hematologic cancer	3.98e-05	0.000299	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—hematologic cancer	3.97e-05	0.000298	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT5A—hematologic cancer	3.89e-05	0.000292	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.88e-05	0.000291	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN2B—hematologic cancer	3.85e-05	0.00029	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3R1—hematologic cancer	3.81e-05	0.000287	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3R1—hematologic cancer	3.8e-05	0.000285	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD86—hematologic cancer	3.73e-05	0.00028	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—JAK2—hematologic cancer	3.71e-05	0.000278	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HES1—hematologic cancer	3.68e-05	0.000276	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NCOR1—hematologic cancer	3.66e-05	0.000275	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CSF2—hematologic cancer	3.61e-05	0.000272	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF1—hematologic cancer	3.61e-05	0.000272	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FOXO1—hematologic cancer	3.56e-05	0.000268	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—hematologic cancer	3.56e-05	0.000267	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFRB—hematologic cancer	3.56e-05	0.000267	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—hematologic cancer	3.53e-05	0.000265	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—hematologic cancer	3.52e-05	0.000265	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—hematologic cancer	3.5e-05	0.000263	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFRA—hematologic cancer	3.5e-05	0.000263	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCG—hematologic cancer	3.49e-05	0.000262	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JAK1—hematologic cancer	3.49e-05	0.000262	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2RA—hematologic cancer	3.26e-05	0.000245	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2—hematologic cancer	3.23e-05	0.000243	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—hematologic cancer	3.22e-05	0.000242	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFB—hematologic cancer	3.14e-05	0.000236	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TSC2—hematologic cancer	3.07e-05	0.000231	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTEN—hematologic cancer	3.03e-05	0.000228	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGFR3—hematologic cancer	2.96e-05	0.000222	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK14—hematologic cancer	2.93e-05	0.00022	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—EP300—hematologic cancer	2.89e-05	0.000217	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—hematologic cancer	2.88e-05	0.000216	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—hematologic cancer	2.87e-05	0.000216	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FN1—hematologic cancer	2.84e-05	0.000213	CbGpPWpGaD
Gabapentin—Feeling abnormal—Dexamethasone—hematologic cancer	2.83e-05	3.61e-05	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—hematologic cancer	2.83e-05	3.61e-05	CcSEcCtD
Gabapentin—Flatulence—Epirubicin—hematologic cancer	2.82e-05	3.6e-05	CcSEcCtD
Gabapentin—Tension—Epirubicin—hematologic cancer	2.81e-05	3.59e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Betamethasone—hematologic cancer	2.81e-05	3.58e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.81e-05	3.58e-05	CcSEcCtD
Gabapentin—Dysgeusia—Epirubicin—hematologic cancer	2.81e-05	3.58e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—NFKBIA—hematologic cancer	2.8e-05	0.000211	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BAD—hematologic cancer	2.8e-05	0.000211	CbGpPWpGaD
Gabapentin—Hypersensitivity—Triamcinolone—hematologic cancer	2.79e-05	3.56e-05	CcSEcCtD
Gabapentin—Nervousness—Epirubicin—hematologic cancer	2.78e-05	3.55e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—NOTCH1—hematologic cancer	2.78e-05	0.000209	CbGpPWpGaD
Gabapentin—Back pain—Epirubicin—hematologic cancer	2.77e-05	3.54e-05	CcSEcCtD
Gabapentin—Malaise—Methotrexate—hematologic cancer	2.76e-05	3.53e-05	CcSEcCtD
Gabapentin—Dizziness—Etoposide—hematologic cancer	2.76e-05	3.52e-05	CcSEcCtD
Gabapentin—Muscle spasms—Epirubicin—hematologic cancer	2.75e-05	3.52e-05	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—hematologic cancer	2.75e-05	3.51e-05	CcSEcCtD
Gabapentin—Vertigo—Methotrexate—hematologic cancer	2.75e-05	3.51e-05	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—hematologic cancer	2.74e-05	3.5e-05	CcSEcCtD
Gabapentin—Leukopenia—Methotrexate—hematologic cancer	2.74e-05	3.5e-05	CcSEcCtD
Gabapentin—Chills—Doxorubicin—hematologic cancer	2.73e-05	3.49e-05	CcSEcCtD
Gabapentin—Urticaria—Betamethasone—hematologic cancer	2.73e-05	3.48e-05	CcSEcCtD
Gabapentin—Urticaria—Dexamethasone—hematologic cancer	2.73e-05	3.48e-05	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.72e-05	3.48e-05	CcSEcCtD
Gabapentin—Dizziness—Prednisolone—hematologic cancer	2.72e-05	3.47e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CD80—hematologic cancer	2.72e-05	0.000204	CbGpPWpGaD
Gabapentin—Asthenia—Triamcinolone—hematologic cancer	2.71e-05	3.47e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—hematologic cancer	2.71e-05	0.000204	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KIT—hematologic cancer	2.71e-05	0.000204	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NRAS—hematologic cancer	2.71e-05	0.000204	CbGpPWpGaD
Gabapentin—Abdominal pain—Dexamethasone—hematologic cancer	2.71e-05	3.47e-05	CcSEcCtD
Gabapentin—Abdominal pain—Betamethasone—hematologic cancer	2.71e-05	3.47e-05	CcSEcCtD
Gabapentin—Body temperature increased—Betamethasone—hematologic cancer	2.71e-05	3.47e-05	CcSEcCtD
Gabapentin—Body temperature increased—Dexamethasone—hematologic cancer	2.71e-05	3.47e-05	CcSEcCtD
Gabapentin—Nausea—Cisplatin—hematologic cancer	2.7e-05	3.45e-05	CcSEcCtD
Gabapentin—Insomnia—Prednisone—hematologic cancer	2.7e-05	3.45e-05	CcSEcCtD
Gabapentin—Vision blurred—Epirubicin—hematologic cancer	2.7e-05	3.45e-05	CcSEcCtD
Gabapentin—Alopecia—Doxorubicin—hematologic cancer	2.69e-05	3.44e-05	CcSEcCtD
Gabapentin—Paraesthesia—Prednisone—hematologic cancer	2.68e-05	3.43e-05	CcSEcCtD
Gabapentin—Pruritus—Triamcinolone—hematologic cancer	2.68e-05	3.42e-05	CcSEcCtD
Gabapentin—Cough—Methotrexate—hematologic cancer	2.67e-05	3.41e-05	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—hematologic cancer	2.67e-05	3.41e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PTPN11—hematologic cancer	2.67e-05	0.0002	CbGpPWpGaD
Gabapentin—Ill-defined disorder—Epirubicin—hematologic cancer	2.66e-05	3.39e-05	CcSEcCtD
Gabapentin—Convulsion—Methotrexate—hematologic cancer	2.65e-05	3.39e-05	CcSEcCtD
Gabapentin—Vomiting—Etoposide—hematologic cancer	2.65e-05	3.39e-05	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—hematologic cancer	2.65e-05	3.38e-05	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—hematologic cancer	2.65e-05	3.38e-05	CcSEcCtD
Gabapentin—Anaemia—Epirubicin—hematologic cancer	2.65e-05	3.38e-05	CcSEcCtD
Gabapentin—Agitation—Epirubicin—hematologic cancer	2.63e-05	3.36e-05	CcSEcCtD
Gabapentin—Dyspepsia—Prednisone—hematologic cancer	2.63e-05	3.36e-05	CcSEcCtD
Gabapentin—Rash—Etoposide—hematologic cancer	2.63e-05	3.36e-05	CcSEcCtD
Gabapentin—Dermatitis—Etoposide—hematologic cancer	2.63e-05	3.36e-05	CcSEcCtD
Gabapentin—Headache—Etoposide—hematologic cancer	2.61e-05	3.34e-05	CcSEcCtD
Gabapentin—Flatulence—Doxorubicin—hematologic cancer	2.61e-05	3.34e-05	CcSEcCtD
Gabapentin—Myalgia—Methotrexate—hematologic cancer	2.61e-05	3.33e-05	CcSEcCtD
Gabapentin—Arthralgia—Methotrexate—hematologic cancer	2.61e-05	3.33e-05	CcSEcCtD
Gabapentin—Chest pain—Methotrexate—hematologic cancer	2.61e-05	3.33e-05	CcSEcCtD
Gabapentin—Tension—Doxorubicin—hematologic cancer	2.6e-05	3.32e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—MAPK3—hematologic cancer	2.6e-05	0.000195	CbGpPWpGaD
Gabapentin—Decreased appetite—Prednisone—hematologic cancer	2.6e-05	3.32e-05	CcSEcCtD
Gabapentin—Dysgeusia—Doxorubicin—hematologic cancer	2.6e-05	3.31e-05	CcSEcCtD
Gabapentin—Rash—Prednisolone—hematologic cancer	2.59e-05	3.31e-05	CcSEcCtD
Gabapentin—Dermatitis—Prednisolone—hematologic cancer	2.59e-05	3.31e-05	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.59e-05	3.31e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CREB1—hematologic cancer	2.58e-05	0.000194	CbGpPWpGaD
Gabapentin—Malaise—Epirubicin—hematologic cancer	2.58e-05	3.3e-05	CcSEcCtD
Gabapentin—Fatigue—Prednisone—hematologic cancer	2.58e-05	3.29e-05	CcSEcCtD
Gabapentin—Headache—Prednisolone—hematologic cancer	2.58e-05	3.29e-05	CcSEcCtD
Gabapentin—Discomfort—Methotrexate—hematologic cancer	2.57e-05	3.29e-05	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—hematologic cancer	2.57e-05	3.29e-05	CcSEcCtD
Gabapentin—Vertigo—Epirubicin—hematologic cancer	2.57e-05	3.29e-05	CcSEcCtD
Gabapentin—Syncope—Epirubicin—hematologic cancer	2.57e-05	3.28e-05	CcSEcCtD
Gabapentin—Leukopenia—Epirubicin—hematologic cancer	2.56e-05	3.27e-05	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—hematologic cancer	2.56e-05	3.27e-05	CcSEcCtD
Gabapentin—Constipation—Prednisone—hematologic cancer	2.56e-05	3.26e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—BRAF—hematologic cancer	2.55e-05	0.000192	CbGpPWpGaD
Gabapentin—Muscle spasms—Doxorubicin—hematologic cancer	2.55e-05	3.25e-05	CcSEcCtD
Gabapentin—Palpitations—Epirubicin—hematologic cancer	2.53e-05	3.23e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CCL2—hematologic cancer	2.53e-05	0.00019	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6R—hematologic cancer	2.52e-05	0.000189	CbGpPWpGaD
Gabapentin—Confusional state—Methotrexate—hematologic cancer	2.52e-05	3.22e-05	CcSEcCtD
Gabapentin—Loss of consciousness—Epirubicin—hematologic cancer	2.52e-05	3.22e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CREBBP—hematologic cancer	2.52e-05	0.000189	CbGpPWpGaD
Gabapentin—Dizziness—Triamcinolone—hematologic cancer	2.5e-05	3.19e-05	CcSEcCtD
Gabapentin—Cough—Epirubicin—hematologic cancer	2.5e-05	3.19e-05	CcSEcCtD
Gabapentin—Anaphylactic shock—Methotrexate—hematologic cancer	2.5e-05	3.19e-05	CcSEcCtD
Gabapentin—Vision blurred—Doxorubicin—hematologic cancer	2.5e-05	3.19e-05	CcSEcCtD
Gabapentin—Convulsion—Epirubicin—hematologic cancer	2.48e-05	3.17e-05	CcSEcCtD
Gabapentin—Infection—Methotrexate—hematologic cancer	2.48e-05	3.17e-05	CcSEcCtD
Gabapentin—Nausea—Etoposide—hematologic cancer	2.48e-05	3.16e-05	CcSEcCtD
Gabapentin—Hypertension—Epirubicin—hematologic cancer	2.47e-05	3.16e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Prednisone—hematologic cancer	2.46e-05	3.15e-05	CcSEcCtD
Gabapentin—Asthenia—Dexamethasone—hematologic cancer	2.46e-05	3.14e-05	CcSEcCtD
Gabapentin—Asthenia—Betamethasone—hematologic cancer	2.46e-05	3.14e-05	CcSEcCtD
Gabapentin—Ill-defined disorder—Doxorubicin—hematologic cancer	2.46e-05	3.14e-05	CcSEcCtD
Gabapentin—Nervous system disorder—Methotrexate—hematologic cancer	2.45e-05	3.13e-05	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—hematologic cancer	2.45e-05	3.13e-05	CcSEcCtD
Gabapentin—Thrombocytopenia—Methotrexate—hematologic cancer	2.45e-05	3.12e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Prednisone—hematologic cancer	2.44e-05	3.12e-05	CcSEcCtD
Gabapentin—Nausea—Prednisolone—hematologic cancer	2.44e-05	3.12e-05	CcSEcCtD
Gabapentin—Arthralgia—Epirubicin—hematologic cancer	2.44e-05	3.11e-05	CcSEcCtD
Gabapentin—Chest pain—Epirubicin—hematologic cancer	2.44e-05	3.11e-05	CcSEcCtD
Gabapentin—Myalgia—Epirubicin—hematologic cancer	2.44e-05	3.11e-05	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—hematologic cancer	2.44e-05	3.11e-05	CcSEcCtD
Gabapentin—Anxiety—Epirubicin—hematologic cancer	2.43e-05	3.1e-05	CcSEcCtD
Gabapentin—Pruritus—Dexamethasone—hematologic cancer	2.43e-05	3.1e-05	CcSEcCtD
Gabapentin—Pruritus—Betamethasone—hematologic cancer	2.43e-05	3.1e-05	CcSEcCtD
Gabapentin—Skin disorder—Methotrexate—hematologic cancer	2.43e-05	3.1e-05	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.42e-05	3.09e-05	CcSEcCtD
Gabapentin—Hyperhidrosis—Methotrexate—hematologic cancer	2.42e-05	3.08e-05	CcSEcCtD
Gabapentin—Discomfort—Epirubicin—hematologic cancer	2.41e-05	3.08e-05	CcSEcCtD
Gabapentin—Vomiting—Triamcinolone—hematologic cancer	2.41e-05	3.07e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MAP2K1—hematologic cancer	2.4e-05	0.00018	CbGpPWpGaD
Gabapentin—Malaise—Doxorubicin—hematologic cancer	2.39e-05	3.05e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—hematologic cancer	2.39e-05	0.000179	CbGpPWpGaD
Gabapentin—Rash—Triamcinolone—hematologic cancer	2.39e-05	3.05e-05	CcSEcCtD
Gabapentin—Dry mouth—Epirubicin—hematologic cancer	2.39e-05	3.05e-05	CcSEcCtD
Gabapentin—Dermatitis—Triamcinolone—hematologic cancer	2.38e-05	3.04e-05	CcSEcCtD
Gabapentin—Vertigo—Doxorubicin—hematologic cancer	2.38e-05	3.04e-05	CcSEcCtD
Gabapentin—Anorexia—Methotrexate—hematologic cancer	2.38e-05	3.04e-05	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—hematologic cancer	2.38e-05	3.04e-05	CcSEcCtD
Gabapentin—Urticaria—Prednisone—hematologic cancer	2.37e-05	3.03e-05	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—hematologic cancer	2.37e-05	3.03e-05	CcSEcCtD
Gabapentin—Headache—Triamcinolone—hematologic cancer	2.37e-05	3.03e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.36e-05	0.000178	CbGpPWpGaD
Gabapentin—Body temperature increased—Prednisone—hematologic cancer	2.36e-05	3.02e-05	CcSEcCtD
Gabapentin—Abdominal pain—Prednisone—hematologic cancer	2.36e-05	3.02e-05	CcSEcCtD
Gabapentin—Confusional state—Epirubicin—hematologic cancer	2.36e-05	3.01e-05	CcSEcCtD
Gabapentin—Diarrhoea—Betamethasone—hematologic cancer	2.35e-05	3e-05	CcSEcCtD
Gabapentin—Diarrhoea—Dexamethasone—hematologic cancer	2.35e-05	3e-05	CcSEcCtD
Gabapentin—Palpitations—Doxorubicin—hematologic cancer	2.34e-05	2.99e-05	CcSEcCtD
Gabapentin—Anaphylactic shock—Epirubicin—hematologic cancer	2.34e-05	2.99e-05	CcSEcCtD
Gabapentin—Oedema—Epirubicin—hematologic cancer	2.34e-05	2.99e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—hematologic cancer	2.34e-05	0.000176	CbGpPWpGaD
Gabapentin—Hypotension—Methotrexate—hematologic cancer	2.33e-05	2.98e-05	CcSEcCtD
Gabapentin—Loss of consciousness—Doxorubicin—hematologic cancer	2.33e-05	2.97e-05	CcSEcCtD
Gabapentin—Infection—Epirubicin—hematologic cancer	2.32e-05	2.97e-05	CcSEcCtD
Gabapentin—Cough—Doxorubicin—hematologic cancer	2.31e-05	2.95e-05	CcSEcCtD
Gabapentin—Shock—Epirubicin—hematologic cancer	2.3e-05	2.94e-05	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—hematologic cancer	2.3e-05	2.93e-05	CcSEcCtD
Gabapentin—Nervous system disorder—Epirubicin—hematologic cancer	2.29e-05	2.93e-05	CcSEcCtD
Gabapentin—Thrombocytopenia—Epirubicin—hematologic cancer	2.29e-05	2.92e-05	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—hematologic cancer	2.29e-05	2.92e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGF2—hematologic cancer	2.28e-05	0.000172	CbGpPWpGaD
Gabapentin—Tachycardia—Epirubicin—hematologic cancer	2.28e-05	2.91e-05	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.28e-05	2.91e-05	CcSEcCtD
Gabapentin—Skin disorder—Epirubicin—hematologic cancer	2.27e-05	2.9e-05	CcSEcCtD
Gabapentin—Dizziness—Betamethasone—hematologic cancer	2.27e-05	2.9e-05	CcSEcCtD
Gabapentin—Dizziness—Dexamethasone—hematologic cancer	2.27e-05	2.9e-05	CcSEcCtD
Gabapentin—Hyperhidrosis—Epirubicin—hematologic cancer	2.26e-05	2.89e-05	CcSEcCtD
Gabapentin—Insomnia—Methotrexate—hematologic cancer	2.26e-05	2.89e-05	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—hematologic cancer	2.26e-05	2.88e-05	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—hematologic cancer	2.26e-05	2.88e-05	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—hematologic cancer	2.26e-05	2.88e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PIK3R1—hematologic cancer	2.25e-05	0.000169	CbGpPWpGaD
Gabapentin—Anxiety—Doxorubicin—hematologic cancer	2.25e-05	2.87e-05	CcSEcCtD
Gabapentin—Nausea—Triamcinolone—hematologic cancer	2.25e-05	2.87e-05	CcSEcCtD
Gabapentin—Paraesthesia—Methotrexate—hematologic cancer	2.24e-05	2.86e-05	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.24e-05	2.86e-05	CcSEcCtD
Gabapentin—Discomfort—Doxorubicin—hematologic cancer	2.23e-05	2.85e-05	CcSEcCtD
Gabapentin—Anorexia—Epirubicin—hematologic cancer	2.23e-05	2.85e-05	CcSEcCtD
Gabapentin—Dyspnoea—Methotrexate—hematologic cancer	2.23e-05	2.84e-05	CcSEcCtD
Gabapentin—Somnolence—Methotrexate—hematologic cancer	2.22e-05	2.84e-05	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—hematologic cancer	2.21e-05	2.82e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Prednisone—hematologic cancer	2.2e-05	2.81e-05	CcSEcCtD
Gabapentin—Dyspepsia—Methotrexate—hematologic cancer	2.2e-05	2.81e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—JAK2—hematologic cancer	2.19e-05	0.000165	CbGpPWpGaD
Gabapentin—Hypotension—Epirubicin—hematologic cancer	2.18e-05	2.79e-05	CcSEcCtD
Gabapentin—Vomiting—Betamethasone—hematologic cancer	2.18e-05	2.79e-05	CcSEcCtD
Gabapentin—Vomiting—Dexamethasone—hematologic cancer	2.18e-05	2.79e-05	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—hematologic cancer	2.18e-05	2.79e-05	CcSEcCtD
Gabapentin—Decreased appetite—Methotrexate—hematologic cancer	2.17e-05	2.77e-05	CcSEcCtD
Gabapentin—Rash—Betamethasone—hematologic cancer	2.16e-05	2.76e-05	CcSEcCtD
Gabapentin—Rash—Dexamethasone—hematologic cancer	2.16e-05	2.76e-05	CcSEcCtD
Gabapentin—Anaphylactic shock—Doxorubicin—hematologic cancer	2.16e-05	2.76e-05	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—hematologic cancer	2.16e-05	2.76e-05	CcSEcCtD
Gabapentin—Dermatitis—Dexamethasone—hematologic cancer	2.16e-05	2.76e-05	CcSEcCtD
Gabapentin—Dermatitis—Betamethasone—hematologic cancer	2.16e-05	2.76e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.16e-05	2.75e-05	CcSEcCtD
Gabapentin—Fatigue—Methotrexate—hematologic cancer	2.15e-05	2.75e-05	CcSEcCtD
Gabapentin—Headache—Betamethasone—hematologic cancer	2.15e-05	2.75e-05	CcSEcCtD
Gabapentin—Headache—Dexamethasone—hematologic cancer	2.15e-05	2.75e-05	CcSEcCtD
Gabapentin—Infection—Doxorubicin—hematologic cancer	2.15e-05	2.74e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—hematologic cancer	2.15e-05	0.000161	CbGpPWpGaD
Gabapentin—Asthenia—Prednisone—hematologic cancer	2.14e-05	2.74e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MDM2—hematologic cancer	2.14e-05	0.000161	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—hematologic cancer	2.14e-05	0.000161	CbGpPWpGaD
Gabapentin—Pain—Methotrexate—hematologic cancer	2.14e-05	2.73e-05	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.13e-05	2.72e-05	CcSEcCtD
Gabapentin—Shock—Doxorubicin—hematologic cancer	2.13e-05	2.72e-05	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—hematologic cancer	2.12e-05	2.71e-05	CcSEcCtD
Gabapentin—Thrombocytopenia—Doxorubicin—hematologic cancer	2.12e-05	2.7e-05	CcSEcCtD
Gabapentin—Pruritus—Prednisone—hematologic cancer	2.11e-05	2.7e-05	CcSEcCtD
Gabapentin—Insomnia—Epirubicin—hematologic cancer	2.11e-05	2.7e-05	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—hematologic cancer	2.11e-05	2.7e-05	CcSEcCtD
Gabapentin—Skin disorder—Doxorubicin—hematologic cancer	2.1e-05	2.68e-05	CcSEcCtD
Gabapentin—Paraesthesia—Epirubicin—hematologic cancer	2.1e-05	2.68e-05	CcSEcCtD
Gabapentin—Hyperhidrosis—Doxorubicin—hematologic cancer	2.09e-05	2.67e-05	CcSEcCtD
Gabapentin—Dyspnoea—Epirubicin—hematologic cancer	2.08e-05	2.66e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—hematologic cancer	2.08e-05	0.000156	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTOR—hematologic cancer	2.08e-05	0.000156	CbGpPWpGaD
Gabapentin—Somnolence—Epirubicin—hematologic cancer	2.08e-05	2.65e-05	CcSEcCtD
Gabapentin—Anorexia—Doxorubicin—hematologic cancer	2.06e-05	2.63e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Methotrexate—hematologic cancer	2.06e-05	2.63e-05	CcSEcCtD
Gabapentin—Dyspepsia—Epirubicin—hematologic cancer	2.06e-05	2.63e-05	CcSEcCtD
Gabapentin—Diarrhoea—Prednisone—hematologic cancer	2.05e-05	2.61e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Methotrexate—hematologic cancer	2.04e-05	2.61e-05	CcSEcCtD
Gabapentin—Nausea—Dexamethasone—hematologic cancer	2.04e-05	2.6e-05	CcSEcCtD
Gabapentin—Nausea—Betamethasone—hematologic cancer	2.04e-05	2.6e-05	CcSEcCtD
Gabapentin—Decreased appetite—Epirubicin—hematologic cancer	2.03e-05	2.6e-05	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—hematologic cancer	2.02e-05	2.58e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.02e-05	2.58e-05	CcSEcCtD
Gabapentin—Fatigue—Epirubicin—hematologic cancer	2.02e-05	2.57e-05	CcSEcCtD
Gabapentin—Pain—Epirubicin—hematologic cancer	2e-05	2.55e-05	CcSEcCtD
Gabapentin—Constipation—Epirubicin—hematologic cancer	2e-05	2.55e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—hematologic cancer	1.99e-05	0.000149	CbGpPWpGaD
Gabapentin—Urticaria—Methotrexate—hematologic cancer	1.98e-05	2.53e-05	CcSEcCtD
Gabapentin—Dizziness—Prednisone—hematologic cancer	1.98e-05	2.52e-05	CcSEcCtD
Gabapentin—Abdominal pain—Methotrexate—hematologic cancer	1.97e-05	2.52e-05	CcSEcCtD
Gabapentin—Body temperature increased—Methotrexate—hematologic cancer	1.97e-05	2.52e-05	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.97e-05	2.52e-05	CcSEcCtD
Gabapentin—Insomnia—Doxorubicin—hematologic cancer	1.96e-05	2.5e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CDKN1B—hematologic cancer	1.95e-05	0.000147	CbGpPWpGaD
Gabapentin—Paraesthesia—Doxorubicin—hematologic cancer	1.94e-05	2.48e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—hematologic cancer	1.93e-05	0.000145	CbGpPWpGaD
Gabapentin—Dyspnoea—Doxorubicin—hematologic cancer	1.93e-05	2.46e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Epirubicin—hematologic cancer	1.93e-05	2.46e-05	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—hematologic cancer	1.92e-05	2.46e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CASP3—hematologic cancer	1.91e-05	0.000144	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.91e-05	2.44e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—IL2—hematologic cancer	1.91e-05	0.000143	CbGpPWpGaD
Gabapentin—Dyspepsia—Doxorubicin—hematologic cancer	1.9e-05	2.43e-05	CcSEcCtD
Gabapentin—Vomiting—Prednisone—hematologic cancer	1.9e-05	2.43e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—IL6—hematologic cancer	1.9e-05	0.000143	CbGpPWpGaD
Gabapentin—Rash—Prednisone—hematologic cancer	1.88e-05	2.41e-05	CcSEcCtD
Gabapentin—Dermatitis—Prednisone—hematologic cancer	1.88e-05	2.4e-05	CcSEcCtD
Gabapentin—Decreased appetite—Doxorubicin—hematologic cancer	1.88e-05	2.4e-05	CcSEcCtD
Gabapentin—Headache—Prednisone—hematologic cancer	1.87e-05	2.39e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.87e-05	2.38e-05	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—hematologic cancer	1.87e-05	2.38e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CCND1—hematologic cancer	1.86e-05	0.00014	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JUN—hematologic cancer	1.86e-05	0.00014	CbGpPWpGaD
Gabapentin—Urticaria—Epirubicin—hematologic cancer	1.86e-05	2.37e-05	CcSEcCtD
Gabapentin—Pain—Doxorubicin—hematologic cancer	1.85e-05	2.36e-05	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—hematologic cancer	1.85e-05	2.36e-05	CcSEcCtD
Gabapentin—Body temperature increased—Epirubicin—hematologic cancer	1.85e-05	2.36e-05	CcSEcCtD
Gabapentin—Abdominal pain—Epirubicin—hematologic cancer	1.85e-05	2.36e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Methotrexate—hematologic cancer	1.84e-05	2.35e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CDKN1A—hematologic cancer	1.8e-05	0.000135	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—hematologic cancer	1.8e-05	0.000135	CbGpPWpGaD
Gabapentin—Asthenia—Methotrexate—hematologic cancer	1.79e-05	2.29e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Doxorubicin—hematologic cancer	1.78e-05	2.28e-05	CcSEcCtD
Gabapentin—Nausea—Prednisone—hematologic cancer	1.78e-05	2.27e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.77e-05	2.26e-05	CcSEcCtD
Gabapentin—Pruritus—Methotrexate—hematologic cancer	1.77e-05	2.26e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MAPK8—hematologic cancer	1.76e-05	0.000132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—hematologic cancer	1.75e-05	0.000132	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—hematologic cancer	1.75e-05	0.000131	CbGpPWpGaD
Gabapentin—Hypersensitivity—Epirubicin—hematologic cancer	1.72e-05	2.2e-05	CcSEcCtD
Gabapentin—Urticaria—Doxorubicin—hematologic cancer	1.72e-05	2.19e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—EP300—hematologic cancer	1.71e-05	0.000129	CbGpPWpGaD
Gabapentin—Abdominal pain—Doxorubicin—hematologic cancer	1.71e-05	2.18e-05	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—hematologic cancer	1.71e-05	2.18e-05	CcSEcCtD
Gabapentin—Diarrhoea—Methotrexate—hematologic cancer	1.71e-05	2.18e-05	CcSEcCtD
Gabapentin—Asthenia—Epirubicin—hematologic cancer	1.68e-05	2.14e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SRC—hematologic cancer	1.67e-05	0.000125	CbGpPWpGaD
Gabapentin—Pruritus—Epirubicin—hematologic cancer	1.65e-05	2.11e-05	CcSEcCtD
Gabapentin—Dizziness—Methotrexate—hematologic cancer	1.65e-05	2.11e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—hematologic cancer	1.62e-05	0.000122	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—hematologic cancer	1.61e-05	0.000121	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRAS—hematologic cancer	1.6e-05	0.00012	CbGpPWpGaD
Gabapentin—Diarrhoea—Epirubicin—hematologic cancer	1.6e-05	2.04e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Doxorubicin—hematologic cancer	1.59e-05	2.04e-05	CcSEcCtD
Gabapentin—Vomiting—Methotrexate—hematologic cancer	1.59e-05	2.03e-05	CcSEcCtD
Gabapentin—Rash—Methotrexate—hematologic cancer	1.58e-05	2.01e-05	CcSEcCtD
Gabapentin—Dermatitis—Methotrexate—hematologic cancer	1.57e-05	2.01e-05	CcSEcCtD
Gabapentin—Headache—Methotrexate—hematologic cancer	1.57e-05	2e-05	CcSEcCtD
Gabapentin—Asthenia—Doxorubicin—hematologic cancer	1.55e-05	1.98e-05	CcSEcCtD
Gabapentin—Dizziness—Epirubicin—hematologic cancer	1.55e-05	1.97e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MAPK3—hematologic cancer	1.54e-05	0.000115	CbGpPWpGaD
Gabapentin—Pruritus—Doxorubicin—hematologic cancer	1.53e-05	1.95e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MYC—hematologic cancer	1.49e-05	0.000112	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—hematologic cancer	1.49e-05	0.000112	CbGpPWpGaD
Gabapentin—Vomiting—Epirubicin—hematologic cancer	1.49e-05	1.9e-05	CcSEcCtD
Gabapentin—Nausea—Methotrexate—hematologic cancer	1.48e-05	1.89e-05	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—hematologic cancer	1.48e-05	1.89e-05	CcSEcCtD
Gabapentin—Rash—Epirubicin—hematologic cancer	1.47e-05	1.88e-05	CcSEcCtD
Gabapentin—Dermatitis—Epirubicin—hematologic cancer	1.47e-05	1.88e-05	CcSEcCtD
Gabapentin—Headache—Epirubicin—hematologic cancer	1.46e-05	1.87e-05	CcSEcCtD
Gabapentin—Dizziness—Doxorubicin—hematologic cancer	1.43e-05	1.83e-05	CcSEcCtD
Gabapentin—Nausea—Epirubicin—hematologic cancer	1.39e-05	1.77e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—KRAS—hematologic cancer	1.38e-05	0.000104	CbGpPWpGaD
Gabapentin—Vomiting—Doxorubicin—hematologic cancer	1.38e-05	1.76e-05	CcSEcCtD
Gabapentin—Rash—Doxorubicin—hematologic cancer	1.36e-05	1.74e-05	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—hematologic cancer	1.36e-05	1.74e-05	CcSEcCtD
Gabapentin—Headache—Doxorubicin—hematologic cancer	1.36e-05	1.73e-05	CcSEcCtD
Gabapentin—Nausea—Doxorubicin—hematologic cancer	1.28e-05	1.64e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—hematologic cancer	1.27e-05	9.53e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—hematologic cancer	1.23e-05	9.21e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—hematologic cancer	1.17e-05	8.81e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—hematologic cancer	1.12e-05	8.43e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—hematologic cancer	1.04e-05	7.78e-05	CbGpPWpGaD
